NCT06181721View on ClinicalTrials.gov

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Diabetes Mellitus
Interventions
DEVICE

Omnipod 5 Automated Glucose Control System

The Omnipod 5 Automated Glucose Control System will provide automated insulin delivery

Trial Locations (1)

8140

University of Otago, Christchurch

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes | Biotech Hunter | Biotech Hunter